Duke Cancer Institute (DCI) recently announced the formation of a new center, Duke Prostate and Urologic Cancer Center, a center of excellence supporting a growing multi-disciplinary translational research team.
Spearheaded by Daniel J. George, MD, professor of medicine and surgery and director of genitourinary oncology at Duke Cancer Institute, the center’s mission is to accelerate research discoveries into the clinic, promote practice changing research and develop promising talent in the prostate and urologic cancer fields. Andrew J. Armstrong, MD, Brant A. Inman, MD, MS, and Cary N. Robertson are associate directors for the center.
“We have built a collaborative powerhouse of faculty and staff from across the university, geared toward tearing down barriers, in dedicated pursuit of ground-breaking research,” said George. “We’re changing the rules on cancer. The center’s mission is to cure more patients of these cancers through multidisciplinary care, education, and clinical, translational and population research.”
Duke Prostate and Urologic Cancer Center will continue developing paradigm-challenging clinical trials with the support of the National Institutes of Health (NIH), the United States Department of Defense (DOD) and numerous foundations. The center’s research will define the biology and genetic drivers of health disparities, discover novel immunotherapy approaches and identify markers and therapeutic targets of aggressive disease in prostate and urologic cancers.
“Building common research infrastructure and shared priorities among our members, demonstrates our commitment and belief in our DCI team of investigators to fulfill our mission,” stated George. “We’re committed to develop nonlinear, innovative research that has the potential to revolutionize our field.”
With the scheduled to launch in April 2018, the center plans to unveil its new “virtual home,” a website that incorporates patient narratives, reports on clinical and translational research breakthroughs, physician and researcher profiles and updates on the advocacy activities of the team. Duke Prostate and Urologic Cancer Center is committed to improving the overall health and wellbeing of its patients through high quality patient care, cutting-edge research and numerous collaborative partnerships and initiatives.
For more information or to apply for membership, please email Daniel George, MD.